Sign inSign up

ADSA Society

Logo
IssuesFor AuthorsAdvertisingNewsHelp

ADSA Society

Search Results

You are looking at 1-10 of 34

A Prospective, Randomized, Double-Blind Comparison of 2% Mepivacaine With 1 : 20,000 Levonordefrin Versus 2% Lidocaine With 1 : 100,000 Epinephrine for Maxillary Infiltrations
Ingrid Lawaty DMD,
 Melissa Drum DDS, MS,
 Al Reader DDS, MS, and
 John Nusstein DDS, MS
Article Category: Research Article
Volume/Issue: Volume 57: Issue 4
Online Publication Date: Jan 01, 2010
DOI: 10.2344/0003-3006-57.4.139
Page Range: 139 – 144

Maxillary infiltration anesthesia is a common method to anesthetize maxillary teeth. A number of studies 1 – 5 have evaluated mepivacaine with epinephrine or levonordefrin in operative dentistry and for surgical procedures. However, electric pulp testing was not performed to evaluate pulpal anesthesia. Hinkley et al, 6 in an experimental study of pulpal anesthesia, have shown that 2% mepivacaine with 1 : 20,000 levonordefrin is equivalent to 2% lidocaine with 1 : 100,000 epinephrine for an inferior alveolar nerve block. Because anesthesia

Download PDF
Figure 1; Incidence of maxillary central incisor pulpal anesthesia as determined by lack of response to electrical pulp testing at the maximum setting (percentage of 80 readings), at each postinjection time interval, for the 2 anesthetic formulations. There were no significant differences (P < .05) between the solutions.
Ingrid Lawaty,
 Melissa Drum,
 Al Reader, and
 John Nusstein
Figure 1
Figure 1

Incidence of maxillary central incisor pulpal anesthesia as determined by lack of response to electrical pulp testing at the maximum setting (percentage of 80 readings), at each postinjection time interval, for the 2 anesthetic formulations. There were no significant differences (P < .05) between the solutions.


Ingrid Lawaty,
 Melissa Drum,
 Al Reader, and
 John Nusstein
Figure 2
Figure 2

Incidence of maxillary first molar pulpal anesthesia as determined by lack of response to electrical pulp testing at the maximum setting (percentage of 80 readings), at each postinjection time interval, for the 2 anesthetic formulations. There were no significant differences (P < .05) between the solutions.


Figure 10.; Cardiovascular influences of norepinephrine (and levonordefrin) versus epinephrine.18 A. Both drugs stimulate Beta1 receptors on cardiac muscle, which increase myocardial contractility. This results in an increase in systolic pressure. B. Both drugs stimulate alpha receptors on vessels, which causes them to constrict. Submucosal vessels contain only alpha receptors, so both drugs produce local vasoconstriction when injected submucosally. But submucosal vessels are not illustrated here; they do not influence diastolic pressure. Systemic arteries influence diastolic pressure and contain Beta2 receptors, which vasodilate and are far more numerous than alpha receptors. Norepinephrine has no affinity for Beta2 receptors and constricts systemic arteries by activating the alpha receptors, even though they are less numerous. This increases diastolic pressure. Epinephrine, which has Beta2 as well as alpha receptor activity, produces vasodilation and a reduction in diastolic pressure. C. Both drugs stimulate Beta1 receptors on the Sino-atrial node, which increases heart rate. But this potential effect from norepinephrine is overridden by a reflex explained as follows. Notice that epinephrine has no influence on mean arterial pressure; systolic pressure increases but diastolic decreases and negates any effect on mean arterial pressure. Norepinephrine increases systolic, diastolic, and mean arterial pressures. The increase in mean arterial pressure stimulates baroreceptors in the carotid sinus, which trigger a vagal slowing of heart rate.
Daniel E. Becker and
 Kenneth L. Reed
Figure 10.
Figure 10.

Cardiovascular influences of norepinephrine (and levonordefrin) versus epinephrine.18 A. Both drugs stimulate Beta1 receptors on cardiac muscle, which increase myocardial contractility. This results in an increase in systolic pressure. B. Both drugs stimulate alpha receptors on vessels, which causes them to constrict. Submucosal vessels contain only alpha receptors, so both drugs produce local vasoconstriction when injected submucosally. But submucosal vessels are not illustrated here; they do not influence diastolic pressure. Systemic arteries influence diastolic pressure and contain Beta2 receptors, which vasodilate and are far more numerous than alpha receptors. Norepinephrine has no affinity for Beta2 receptors and constricts systemic arteries by activating the alpha receptors, even though they are less numerous. This increases diastolic pressure. Epinephrine, which has Beta2 as well as alpha receptor activity, produces vasodilation and a reduction in diastolic pressure. C. Both drugs stimulate Beta1 receptors on the Sino-atrial node, which increases heart rate. But this potential effect from norepinephrine is overridden by a reflex explained as follows. Notice that epinephrine has no influence on mean arterial pressure; systolic pressure increases but diastolic decreases and negates any effect on mean arterial pressure. Norepinephrine increases systolic, diastolic, and mean arterial pressures. The increase in mean arterial pressure stimulates baroreceptors in the carotid sinus, which trigger a vagal slowing of heart rate.


Paul A. Moore DMD, PhD, MPH
Article Category: Research Article
Volume/Issue: Volume 54: Issue 4
Online Publication Date: Jan 01, 2007
Page Range: 175 – 177

zomepirac (Zomax). In 1981, Samuel reported a case of anaphylactic shock associated with its use. 7 Several additional reports followed as practitioners began to recognize the anaphylactoid potential of zomepirac. Eventually, the drug was removed from the market. Consider the drug interaction between levonordefrin (Neocobefrin) and propranolol (Inderal) reported by Mito and Yagiela. 8 Prior to this report, the potential for a nonselective beta-adrenergic antagonist to induce a hypertensive response following the injection of a dental local anesthetic containing

Joao Paulo Steffens DDS, MSc,
 Márcia Thaís Pochapski DDS, MSc, PhD,
 Fábio André Santos DDS, MSc, PhD, and
 Gibson Luiz Pilatti DDS, MSc, PhD
Article Category: Research Article
Volume/Issue: Volume 58: Issue 2
Online Publication Date: Jan 01, 2011
Page Range: 57 – 60

%), being related to a more severe increase in blood pressure. 15 Although norepinephrine is more stable in solution and requires fewer preservatives, 6 it was removed from many formulations, making it difficult for this study to be compared with others previously published. In the United States, mepivacaine is used in conjunction with 1 ∶ 20,000 levonordefrin, a vasoconstrictor with action similar to that of norepinephrine. Levonordefrin has a lack of activity at beta-2 receptors and less alpha-1 activity than norepinephrine. 16 Pulp anesthesia using 2% lidocaine with

Daniel E. Becker DDS and
 Kenneth L. Reed DMD
Article Category: Research Article
Volume/Issue: Volume 53: Issue 3
Online Publication Date: Jan 01, 2006
Page Range: 98 – 109

epinephrine or levonordefrin. To clarify several misconceptions regarding allergic reactions, a brief review of their pathogenesis is in order as presented by Adkinson. 7 For drugs to be immunogenic, they must be of large molecular weight and possess multiple valences to be recognized by the immune cells. Large proteins such as insulin fulfill these requirements and are well established as immunogenic. Most other molecules are too small and must combine with other molecules that act as carriers, in which case the drug is described as a hapten. This complex of a

Daniel E Becker DDS
Article Category: Research Article
Volume/Issue: Volume 58: Issue 1
Online Publication Date: Jan 01, 2011
Page Range: 31 – 41

metabolized in the liver by MAO, but catecholamines are inactivated by catechol‐o‐methyltransferase (COMT). Epinephrine and levonordefrin are catecholamines and are metabolized primarily by COMT, not MAO. MAO inhibitors do not delay their elimination. Novel agents that enhance dopaminergic activity are being introduced in the management of Parkinson's disease. One of these, entacapone (Comtan), is a COMT inhibitor that may delay metabolism of both epinephrine and levonordefrin. Should this interaction occur, the normally transient duration of cardiovascular stimulation

Daniel E. Becker DDS
Article Category: Other
Volume/Issue: Volume 59: Issue 4
Online Publication Date: Jan 01, 2012
Page Range: 159 – 169

catecholamine structure are primarily inactivated by COMT, whereas most noncatecholamines are metabolized by MAO. Termination by COMT is a very rapid process and accounts for the very short elimination half-life of catecholamines, generally 1–3 minutes. Epinephrine and levonordefrin, the principal vasopressors used with local anesthetics, are both catecholamines. Their principal method of termination is hepatic biotransformation, with COMT acting as the primary enzyme; MAO has little significance. For this reason, antidepressants that inhibit this enzyme (MAO inhibitors) do

Daniel E Becker DDS and
 Kenneth L Reed DMD
Article Category: Research Article
Volume/Issue: Volume 59: Issue 2
Online Publication Date: Jan 01, 2012
Page Range: 90 – 102

palpitations attributed to epinephrine contained either in the solution or released endogenously. Allergic reactions following local anesthetic injections are more likely attributable to preservatives (methylparaben) or antioxidants (sulfites) contained in the solution. 7 Methylparaben is included in multidose vials to prevent microbial growth. It is no longer found in single-dose vials or dental cartridges. Sulfites prevent the oxidation of vasopressors and are included only in those dental cartridges containing epinephrine or levonordefrin. Allergic reactions

ANPR logo
AboutIssuesAuthor InformationSubscriptions

ADSA Society

eISSN: 1878-7177

ISSN: 0003-3006

Powered by PubFactory